Location: Irvine, CA
Cap-Exempt H-1B Position — No lottery required
Overview: Founded in 1965, **UC Irvine** is a member of the prestigious Association of American Universities and is ranked among the nation’s top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UC Irvine has more than 36,000 students and offers 224 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. To learn more about UC Irvine, visit www.uci.edu. The NCI-designated Chao Family Comprehensive Cancer Center (CFCCC) is a campus-wide multidisciplinary matrix organization whose goal is to promote and enhance cancer-relevant research and patient care at UC Irvine. The CFCCC provides research resources to its Cancer Center members engaged in research and offers multidisciplinary cancer care to its patients. As the CFCCC's centralized office for cancer clinical research operations, the Stern Center provides high-quality, cost effective and efficient assistance with developing, activating and completing scientifically impactful cancer clinical trials. The Stern Center consolidates the management of cancer clinical research operations and is a visionary and best-practice leader in clinical research operations at the institution, managing the largest portfolio of clinical trials at UCI. At any given time, the CFCCC Stern Center manages a very large clinical trials portfolio (~400 active, or in-development). With this large and dynamic clinical trial portfolio, the CFCCC consistently maintains a proportional amount of accounts receivable (~$13M) for work performed and costs incurred. In order to minimize significant financial risk to the University and ensure the success of the mission of the CFCCC, it is critical these funds be p